<!DOCTYPE html>

<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Characterization of pancreatic glucagon-producing tumors and pituitary gland tumors in transgenic mice overexpressing MYCN in hGFAP-positive cells.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Characterization of pancreatic glucagon-producing tumors and pituitary gland tumors in transgenic mice overexpressing MYCN in hGFAP-positive cells." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ac7/5342675/b9dbf19ba062/oncotarget-07-74415-g003.jpg"/> </div> <div class="text-side"> <h1>Characterization of pancreatic glucagon-producing tumors and pituitary gland tumors in transgenic mice overexpressing MYCN in hGFAP-positive cells.</h1> <p>Immunohistochemistry of brain tumors in LSL-MYCN;hGFAP-Cre mice confirmed their neuroendocrine originA., B. H&amp;E stained sections of tumors arising in the pituitary gland at lower and higher magnification, respectively. C. Positive chromogranin A immunostaining of a pituitary tumor. Bars, 50 μm. D. Normalized MYCN mRNA expression in a series of nine human PanNETs. MYCN expression was normalized to the expression of β-Actin and this value was set to “1” in the positive control, a human neuroblastoma cell line with high MYCN levels due to an amplification of the MYCN oncogene. The horizontal line depicts a threshold of 5% of MYCN expression in the positive control.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/27769070/" target="_blank">27769070</a></p><p>Type: Premalignant/Malignant, Category: Neural or neuroendocrine</p>
</div> </div></div></body></html>